Translating the science of quality of life into practice: What do dermatology life quality index scores mean?
By Hongbo Yan, Charles L. Thomas, Michael A. Harrison, M. Salek, A. Finlay. Journal of Investigative Dermatology, 2005
812 citations recorded by the source corpus.
Subfields: Dermatology, Economics and Econometrics, Immunology
View Paper: https://www.semanticscholar.org/paper/199a293960de4452e65fd48c1638fddab5099621
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Armstrong
- A. Gottlieb
- K. Papp
- A. Kimball
- U. Mrowietz
- K. Reich
- N. Korman
- M. Okun
Citations in the corpus
- Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa. (2016, background): “A score of 0 or 1 indicates no effect, 2 to 5 a small effect, 6 to 10 a moderate effect, 11 to 20 a very large effect, and 21 to 30 an extremely large effect.(20) Table 1.”
- European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa (2015, methodology): “According to the Global Question (GQ) indexing, 19 HS impact on QoL was estimated as having large or extremely large effect on patient’s life for nearly 60% of examined patients.”
- Definition of treatment goals for moderate to severe psoriasis: a European consensus (2010, methodology): “2) based on a categorization study of the DLQI [11].”